PE/VC  Gilde Healthcare Partners

https://gildehealthcare.com/





     Office Locations:

Stadsplateau 36
Utrecht, 3521
Netherlands
Phone: +31 30 219 25 65

Get all office locations for this firm with a National Database subscription.
 

Stages:

  • Early
  • Expansion
  • Growth
  • Middle Market


 

Industries:

  • Energy & Clean Tech
  • Life Sciences & Healthcare

  •  

    Description:

    Gilde Healthcare is a specialist private investment firm with EURO3bn under management across three fund strategies: Venture&Growth in Healthcare, Private Equity in Healthcare and Private Equity in Climate Solutions. The firm's headquarters are in Utrecht, the Netherlands with local offices in Frankfurt, Germany and Boston. Gilde Healthcare Venture&Growth invests in healthtech and therapeutics. The Venture&Growth fund supports fast growing companies in Europe and North America. Gilde Healthcare Private Equity participates in profitable lower mid-market companies including healthcare providers, suppliers of medical products and service providers to the healthcare sector. The Climate Solutions Private Equity fund invests in profitable lower mid market companies active in energy transition, biodiversity and waste & pollution



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Arthur Franken General Partner
    David de Graaf General Partner
    Edwin de Graaf Managing Partner
    Geoff Pardo General Partner
    Hein Ploegmakers General Partner

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      06/02/2025


      SpyGlass Pharma


      CA


      $75,000,000


      Series D


      03/14/2025


      MicroTransponder


      TX


      $65,000,000


      Series F


     

    Portfolio companies include:

     

    Recent News: